Clinical Trials Directory

Trials / Unknown

UnknownNCT03114774

Effectivity of Bispectral Index Monitoring in Cases of Endoscopic Retrograde Cholangiopancreatography

Evaluation of Effectivity of Bispectral Index Monitoring in Cases of Endoscopic Retrograde Cholangiopancreatography Received Sedoanalgesia

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Istanbul Medeniyet University · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers

Summary

The bispectral index (BIS) monitoring is an EEG-based method that uses electroencephalogram analysis and a complex algorithm to generate a numerical scoring 0-100 (0 flat line EEG, 100, wide awake) BIS monitoring allows noninvasive, objective measurement of level of consciousness of a sedated patient. A limited number of studies have used measurements of BIS monitoring to assist endoscopic sedation.There are studies using BIS monitoring to make sedation easy for ERCP procedures. However, the studies evaluating use of BIS for gastrointestinal endoscopy show inconsistent results. The objective of this study is to evaluate effects of sedation on the dosage of propofol by monitoring with BIS values, hemodynamics, recovery parameters, respiratory functions and endoscopist satisfaction based on the hypothesis that the investigators would reduce the risk for respiratory depression using minimal doses of propofol in order to achieve the desired level of sedation with BIS monitoring.

Conditions

Interventions

TypeNameDescription
DEVICEThe bispectral index (BIS) monitoring
BEHAVIORALRamsay Sedation Scale (RSS) Score monitoring

Timeline

Start date
2017-04-15
Primary completion
2017-05-01
Completion
2017-06-01
First posted
2017-04-14
Last updated
2017-04-14

Source: ClinicalTrials.gov record NCT03114774. Inclusion in this directory is not an endorsement.